• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 蛋白与卡介苗、OPV、MMR 等疫苗中抗原蛋白的计算机比较研究:可能具有保护作用的证据。

In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect.

机构信息

Laboratory of Clinical Virology, WHO Regional Reference Laboratory for Poliomyelitis and Measles for the EMR, Institut Pasteur de Tunis, University of Tunis El Manar, 13 place Pasteur, BP74 1002 le Belvédère, Tunis, Tunisia.

LR20IPT10 Laboratory of Virus, Host and Vectors, Institut Pasteur de Tunis, University of Tunis El Manar, Tunis, Tunisia.

出版信息

BMC Bioinformatics. 2021 Mar 26;22(1):163. doi: 10.1186/s12859-021-04045-3.

DOI:10.1186/s12859-021-04045-3
PMID:33771096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7995392/
Abstract

BACKGROUND

Coronavirus Disease 2019 (COVID-19) is a viral pandemic disease that may induce severe pneumonia in humans. In this paper, we investigated the putative implication of 12 vaccines, including BCG, OPV and MMR in the protection against COVID-19. Sequences of the main antigenic proteins in the investigated vaccines and SARS-CoV-2 proteins were compared to identify similar patterns. The immunogenic effect of identified segments was, then, assessed using a combination of structural and antigenicity prediction tools.

RESULTS

A total of 14 highly similar segments were identified in the investigated vaccines. Structural and antigenicity prediction analysis showed that, among the identified patterns, three segments in Hepatitis B, Tetanus, and Measles proteins presented antigenic properties that can induce putative protective effect against COVID-19.

CONCLUSIONS

Our results suggest a possible protective effect of HBV, Tetanus and Measles vaccines against COVID-19, which may explain the variation of the disease severity among regions.

摘要

背景

2019 年冠状病毒病(COVID-19)是一种病毒性大流行疾病,可在人类中引起严重肺炎。在本文中,我们研究了 12 种疫苗(包括卡介苗、口服脊髓灰质炎疫苗和麻疹腮腺炎风疹联合疫苗)对 COVID-19 的可能保护作用。比较了研究疫苗和 SARS-CoV-2 蛋白的主要抗原蛋白的序列,以确定相似模式。然后,使用结构和抗原性预测工具的组合评估鉴定片段的免疫原性效应。

结果

在研究的疫苗中总共鉴定出 14 个高度相似的片段。结构和抗原性预测分析表明,在鉴定出的模式中,乙型肝炎、破伤风和麻疹蛋白中的三个片段具有抗原特性,可诱导针对 COVID-19 的假定保护作用。

结论

我们的结果表明乙型肝炎、破伤风和麻疹疫苗对 COVID-19 可能具有保护作用,这可以解释不同地区疾病严重程度的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/8004428/d0b1e4dc70db/12859_2021_4045_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/8004428/df0f816b0816/12859_2021_4045_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/8004428/d0b1e4dc70db/12859_2021_4045_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/8004428/df0f816b0816/12859_2021_4045_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d6a/8004428/d0b1e4dc70db/12859_2021_4045_Fig2_HTML.jpg

相似文献

1
In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect.SARS-CoV-2 蛋白与卡介苗、OPV、MMR 等疫苗中抗原蛋白的计算机比较研究:可能具有保护作用的证据。
BMC Bioinformatics. 2021 Mar 26;22(1):163. doi: 10.1186/s12859-021-04045-3.
2
Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.重新利用儿童疫苗:我们能否训练免疫系统对抗 SARS-CoV-2。
Expert Rev Vaccines. 2021 Sep;20(9):1051-1057. doi: 10.1080/14760584.2021.1960161. Epub 2021 Aug 6.
3
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.BCG 疫苗可能会产生针对 SARS-CoV-2 的交叉反应性 T 细胞:计算机分析与假设。
Vaccine. 2020 Sep 22;38(41):6352-6356. doi: 10.1016/j.vaccine.2020.08.045. Epub 2020 Aug 20.
4
Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).基于免疫信息学设计针对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 的基于表位的亚单位疫苗。
Immunobiology. 2020 May;225(3):151955. doi: 10.1016/j.imbio.2020.151955. Epub 2020 May 11.
5
Biological Rationale for the Repurposing of BCG Vaccine against SARS-CoV-2.BCG 疫苗针对 SARS-CoV-2 再利用的生物学基础。
J Proteome Res. 2020 Nov 6;19(11):4649-4654. doi: 10.1021/acs.jproteome.0c00410. Epub 2020 Aug 28.
6
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.用于 COVID-19 的疫苗:从核酸疫苗到作为传递载体系统的卡介苗的观点。
Microbes Infect. 2020 Nov-Dec;22(10):515-524. doi: 10.1016/j.micinf.2020.09.004. Epub 2020 Sep 19.
7
Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.SARS-CoV-2 包膜蛋白与分枝杆菌属抗原之间具有很强的同源性,这使得分枝杆菌属感染的快速诊断成为可能,并且卡介苗疫苗可能通过提供针对 SARS-CoV-2 的特异性免疫力。
Ann Diagn Pathol. 2020 Oct;48:151600. doi: 10.1016/j.anndiagpath.2020.151600. Epub 2020 Aug 13.
8
Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.人工智能预测 SARS-CoV-2 的免疫原性景观,从而为疫苗设计提供通用蓝图。
Sci Rep. 2020 Dec 23;10(1):22375. doi: 10.1038/s41598-020-78758-5.
9
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告:评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
10
Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.基于表位的新型冠状病毒病 SARS-CoV-2 肽疫苗预测。
Virus Res. 2020 Oct 15;288:198082. doi: 10.1016/j.virusres.2020.198082. Epub 2020 Jul 1.

引用本文的文献

1
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial.卡介苗复种对乌干达城市青少年接种无关疫苗反应的影响(POPVAC C):一项开放标签、随机对照试验。
Lancet Glob Health. 2024 Nov;12(11):e1849-e1859. doi: 10.1016/S2214-109X(24)00282-1.
2
The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria-Tetanus-Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring the Roles of Heterologous Immunity.印度尼西亚儿童接种白喉-破伤风-百日咳疫苗和新冠病毒疫苗后对新冠病毒适应性免疫反应的改善:探索异源免疫的作用
Vaccines (Basel). 2024 Sep 9;12(9):1032. doi: 10.3390/vaccines12091032.
3

本文引用的文献

1
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
2
Lockdown measures in response to COVID-19 in nine sub-Saharan African countries.针对 COVID-19 的封锁措施在撒哈拉以南非洲的九个国家实施。
BMJ Glob Health. 2020 Oct;5(10). doi: 10.1136/bmjgh-2020-003319.
3
SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys.
Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
灭活的 SARS-CoV-2 加强疫苗增强了慢性肝病患者的免疫应答。
Virol Sin. 2023 Oct;38(5):723-734. doi: 10.1016/j.virs.2023.07.005. Epub 2023 Jul 22.
4
Multidimensional futuristic approaches to address the pandemics beyond COVID-19.应对新冠疫情之外的大流行病的多维未来主义方法。
Heliyon. 2023 Jun;9(6):e17148. doi: 10.1016/j.heliyon.2023.e17148. Epub 2023 Jun 11.
5
Immunoinformatics Identification of the Conserved and Cross-Reactive T-Cell Epitopes of SARS-CoV-2 with Human Common Cold Coronaviruses, SARS-CoV, MERS-CoV and Live Attenuated Vaccines Presented by HLA Alleles of Indonesian Population.免疫信息学鉴定 SARS-CoV-2 与人类普通感冒冠状病毒、SARS-CoV、MERS-CoV 以及印度尼西亚人群 HLA 等位基因呈递的减毒活疫苗的保守和交叉反应性 T 细胞表位。
Viruses. 2022 Oct 24;14(11):2328. doi: 10.3390/v14112328.
6
Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review.卡介苗接种政策在降低 COVID-19 感染和死亡率方面的有效性:系统评价。
Glob Health Res Policy. 2022 Nov 7;7(1):42. doi: 10.1186/s41256-022-00275-x.
7
Inspiration to mRNA-based COVID-19 vaccination: Serious adverse case reports with hepatitis B vaccine in real-world.基于mRNA的新冠疫苗接种的启示:现实世界中乙肝疫苗的严重不良事件报告
Front Pediatr. 2022 Sep 23;10:888686. doi: 10.3389/fped.2022.888686. eCollection 2022.
8
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era.德尔塔(B.1.617.2)和奥密克戎(B.1.1.529)变异株流行时期儿童人群中 SARS-CoV-2 感染情况。
Virol J. 2022 Sep 8;19(1):144. doi: 10.1186/s12985-022-01873-4.
9
Beneficial non-specific effects of live vaccines against COVID-19 and other unrelated infections.新冠病毒和其他不相关感染的活疫苗的有益非特异性效应。
Lancet Infect Dis. 2023 Jan;23(1):e34-e42. doi: 10.1016/S1473-3099(22)00498-4. Epub 2022 Aug 26.
10
Presumed Protective Role for Anti-Hepatitis B Virus Antibodies Against COVID-19 Severe Cases: A Clinical Study Confirming Hypothesis.抗乙型肝炎病毒抗体对新型冠状病毒肺炎重症病例的假定保护作用:一项证实假设的临床研究
Front Med (Lausanne). 2022 Jul 8;9:909660. doi: 10.3389/fmed.2022.909660. eCollection 2022.
巴西的 SARS-CoV-2 抗体流行率:两项连续全国血清学家庭调查结果。
Lancet Glob Health. 2020 Nov;8(11):e1390-e1398. doi: 10.1016/S2214-109X(20)30387-9. Epub 2020 Sep 23.
4
Unlocking COVID therapeutic targets: A structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike.解锁新冠病毒治疗靶点:基于结构的抗严重急性呼吸综合征冠状病毒2、严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒刺突蛋白的理论依据。
Comput Struct Biotechnol J. 2020 Jul 31;18:2117-2131. doi: 10.1016/j.csbj.2020.07.017. eCollection 2020.
5
Targeting TMPRSS2 in SARS-CoV-2 Infection.针对 SARS-CoV-2 感染中的 TMPRSS2。
Mayo Clin Proc. 2020 Sep;95(9):1989-1999. doi: 10.1016/j.mayocp.2020.06.018. Epub 2020 Jul 19.
6
Pediatric COVID-19 Disease: A Review of the Recent Literature.儿童新冠病毒疾病:近期文献综述
Pediatr Ann. 2020 Jul 1;49(7):e319-e325. doi: 10.3928/19382359-20200615-01.
7
A perspective on potential antibody-dependent enhancement of SARS-CoV-2.对 SARS-CoV-2 潜在抗体依赖性增强作用的看法。
Nature. 2020 Aug;584(7821):353-363. doi: 10.1038/s41586-020-2538-8. Epub 2020 Jul 13.
8
BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).BCG 疫苗可预防严重的 2019 年冠状病毒病(COVID-19)。
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):17720-17726. doi: 10.1073/pnas.2008410117. Epub 2020 Jul 9.
9
Comparative genomic signature representations of the emerging COVID-19 coronavirus and other coronaviruses: High identity and possible recombination between Bat and Pangolin coronaviruses.新兴的 COVID-19 冠状病毒与其他冠状病毒的比较基因组特征表示:蝙蝠和穿山甲冠状病毒之间具有高度的同一性和可能的重组。
Genomics. 2020 Nov;112(6):4189-4202. doi: 10.1016/j.ygeno.2020.07.003. Epub 2020 Jul 6.
10
Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients.从新冠肺炎患者中挖掘严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白上的表位
Cell Res. 2020 Aug;30(8):702-704. doi: 10.1038/s41422-020-0366-x. Epub 2020 Jul 1.